CLASS II Device recall · Reported 21 Mar 2018 · FDA Enforcement Report

NaturaLyte¿ Liquid Acid Concentrate 2.0 mEq/L recalled

Fresenius Medical Care Renal Therapies Group is recalling NaturaLyte¿ Liquid Acid Concentrate 2.0 mEq/L, distributed in California, Florida, Kansas, Louisiana, Texas. The recall was initiated on 29 Sep 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 17KTAC076; UDI-00840861101696
Quantity recalled598 cases

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1010-2018
FDA event ID
79236
Classification
Class II
Status
Terminated
Recall initiated
29 Sep 2017
FDA classified
14 Mar 2018
Reported
21 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Other Reasons

Timeline

29 Sep 2017Recall initiated by company
14 Mar 2018Classified by FDA+166 days
21 Mar 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The label specifies the potassium concentration is 2.0 mEq/L. Some of the product in the affected lot was found to have a potassium concentration of 2.25 mEq/L.

Product as listed by the FDA

NaturaLyte¿ Liquid Acid Concentrate 2.0 mEq/L, Model # 08-2251-0 3.43 liter bottle This concentrate is formulated to be used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Where it was distributed

US Distribution to states of: CA, FL, KS, LA, and TX.

CaliforniaFloridaKansasLouisianaTexas

Questions about this recall

Why was it recalled?

The label specifies the potassium concentration is 2.0 mEq/L. Some of the product in the affected lot was found to have a potassium concentration of 2.25 mEq/L.

Which lots are affected?

Lot # 17KTAC076; UDI-00840861101696

Where was it sold?

US Distribution to states of: CA, FL, KS, LA, and TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Medical Care Renal Therapies Group

All 34

Other Other Medical Devices recalls

All 13,778